| A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM) (NCT02200640) | Boehringer Ingelheim | 2000-03-01 |
| Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women. (NCT03921736) | Anna Posadzy-Małaczyńska | 2000-01-10 |
| Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy (NCT02177500) | Boehringer Ingelheim | 2000-01-01 |
| Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients (NCT02172586) | Boehringer Ingelheim | 2000-01-01 |
| Exploring the Comorbidity Between Mental Disorders and General Medical Conditions (NCT03847753) | University of Aarhus | 2000-01-01 |
| Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model (NCT00074633) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-01-01 |
| Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects (NCT00001963) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-12-01 |
| Micardis®. Observational Study in Patients With Essential Hypertension (NCT02200094) | Boehringer Ingelheim | 1999-12-01 |
| A Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension (NCT03276598) | Helsinki University Central Hospital | 1999-11-25 |
| Genetic Analysis of African-Americans With High Blood Pressure (NCT00353925) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-10-05 |
| Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH) (NCT02175355) | Boehringer Ingelheim | 1999-10-01 |
| Blood Sampling for Neurochemical and Genetic Testing (NCT00001147) | National Institute of Neurological Disorders and Stroke (NINDS) | 1999-10-01 |
| Genetic Mechanisms in Human Hypertension (NCT01456208) | Brigham and Women's Hospital | 1999-10-01 |
| Genetics of Hypertension Associated Treatments (GenHAT) (NCT00006294) | Donna Arnett, 257-5678 | 1999-09-01 |
| Observational Cohort Study of Sodium, Weight and Cardiovascular Disease (NCT00006308) | Brigham and Women's Hospital | 1999-09-01 |
| Adherence to Antihypertensive Therapy--Data Analyses (NCT00006552) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-09-01 |
| Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension (NCT02242370) | Boehringer Ingelheim | 1999-09-01 |
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) (NCT00000620) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-09-01 |
| Epidemiology of Coronary Calcification in the Elderly (NCT00005756) | University of Pittsburgh | 1999-08-01 |
| Physical Fitness and Cardiovascular Mortality in Firefighters (NCT00005540) | University of Southern California | 1999-07-01 |
| Birth Weight Effect on Blood Pressure in Late Childhood (NCT00006322) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-07-01 |
| Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension (NCT02177487) | Boehringer Ingelheim | 1999-06-01 |
| Pharmacovigilance and Patient Compliance in Hypertensive Patients (NCT02200575) | Boehringer Ingelheim | 1999-05-01 |
| Micardis® in Patients With Essential Hypertension (NCT02187705) | Boehringer Ingelheim | 1999-05-01 |
| Sleep Apnea in a Non-Clinical Population (NCT00005551) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-04-01 |
| Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension (NCT02176499) | Boehringer Ingelheim | 1999-02-01 |
| Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension (NCT02177435) | Boehringer Ingelheim | 1999-02-01 |
| Multi-Ethnic Study of Atherosclerosis (MESA) (NCT00005487) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-01-01 |
| Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension (NCT02176850) | Boehringer Ingelheim | 1999-01-01 |
| Diabetes and Heart Disease Risk in Blacks (NCT00001853) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-10-21 |
| Framingham Nutrition Studies (NCT00005513) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-09-01 |
| PREMIER: Lifestyle Interventions for Blood Pressure Control (NCT00000616) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-09-01 |
| Hypertensive Treatment and Epidemiological Analyses (NCT00005501) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-09-01 |
| BIBR 277 Capsule in Patients With Essential Hypertension (NCT02177448) | Boehringer Ingelheim | 1998-09-01 |
| Genetic Epidemiology--Development of Cardiovascular Risk (NCT00005512) | Virginia Commonwealth University | 1998-08-01 |
| BIBR 277 Capsules in Hypertensive Patients With Nephropathy (NCT02187484) | Boehringer Ingelheim | 1998-08-01 |
| TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial (NCT00227318) | AstraZeneca | 1998-07-01 |
| Primary Prevention of CHD Risk Factors Occurring in US (NCT00005495) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-07-01 |
| Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes (NCT06545461) | Donald Wesson | 1998-06-22 |
| Exercise and Blood Pressure in Children: A Meta-Analysis (NCT00005521) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-06-01 |
| Pharmacokinetics of BIBR 277 in Hypertensive Patients (NCT02187497) | Boehringer Ingelheim | 1998-06-01 |
| Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension (NCT02235415) | Boehringer Ingelheim | 1998-06-01 |
| Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension (NCT02177422) | Boehringer Ingelheim | 1998-06-01 |
| Stress Reduction and Prevention of Hypertension in Blacks (NCT00005748) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-05-01 |
| Effect of Caldine® on Renal Function in Balanced Hypertension (NCT02240641) | Boehringer Ingelheim | 1998-05-01 |
| Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases (NCT00001723) | Jack Yanovski | 1998-05-01 |
| Racial Differences in Control of Blood Vessel Tone and Blood Flow (NCT00001747) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-05-01 |
| Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension (NCT02177409) | Boehringer Ingelheim | 1998-04-01 |
| Felodipine Event Reduction Study (NCT01136863) | Chinese Academy of Medical Sciences | 1998-04-01 |
| Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension (NCT02183701) | Boehringer Ingelheim | 1998-04-01 |
| MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (NCT02177396) | Boehringer Ingelheim | 1998-04-01 |
| The Role of Cyclooxygenase Activity in the Endothelial Function of Hypertensive and Hypercholesterolemic Patients (NCT00001742) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-02-01 |
| Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients (NCT00221845) | Heidelberg University | 1998-01-01 |
| Consequences and Correlates of Weight Fluctuations (NCT00005745) | National Heart, Lung, and Blood Institute (NHLBI) | 1998-01-01 |
| Salt Sensitivity, Cardiovascular and Metabolic Disease (NCT00005489) | Indiana University | 1998-01-01 |
| The Risk of Hypertension Associated With Oral Glucocorticoids in Chronic Inflammatory Diseases (NCT03760562) | University of Leeds | 1998-01-01 |
| A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients (NCT02235402) | Boehringer Ingelheim | 1997-12-01 |
| A Cohort Study of Morning Home Blood Pressure Measurement in Type 2 Diabetic Patients (NCT00760110) | Nagaoka Red Cross Hospital | 1997-11-01 |
| INVEST: INternational VErapamil SR Trandolapril STudy (NCT00133692) | University of Florida | 1997-09-01 |
| Racial Variation in ACE--Genetic and Physiologic Bases (NCT00005757) | Vanderbilt University | 1997-09-01 |
| The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function (NCT00001629) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-07-01 |
| DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril (NCT00274118) | Boehringer Ingelheim | 1997-07-01 |
| Effect of Aerobic Exercise on Blood Pressure Changes (NCT00358137) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-07-01 |
| Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD) (NCT00005536) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-07-01 |
| The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function (NCT00001628) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-07-01 |
| Treatment of Hypertension With Two Exercise Intensities (NCT00004561) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-06-01 |
| Methods for Measuring Insulin Sensitivity (NCT00001625) | National Center for Complementary and Integrative Health (NCCIH) | 1997-04-03 |
| A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) (NCT00235014) | Abbott | 1997-03-01 |
| Study of the Response of Human Small Blood Vessels (NCT00001622) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-03-01 |
| Dietary Patterns, Sodium Intake and Blood Pressure (DASH - Sodium) (NCT00000608) | National Heart, Lung, and Blood Institute (NHLBI) | 1997-02-01 |
| Genetic Epidemiology of Responses to Antihypertensives (NCT00005520) | Mayo Clinic | 1997-02-01 |
| Job Strain, Ambulatory Blood Pressure and Hypertension (NCT00005472) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Divergence of Blood Pressure By Race in Adolescent Girls (NCT00005470) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Precursors of CVD Risk Factors--Project Heartbeat (NCT00005478) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Sociodemographic Regulation of Cardiovascular Function and Structure (NCT00005476) | National Heart, Lung, and Blood Institute (NHLBI) | 1996-09-01 |
| Cohort Study of Heart Rate Variability (NCT00005399) | University of North Carolina, Chapel Hill | 1996-08-01 |
| Dietary Acid Reduction and Progression of Chronic Kidney Disease (NCT06046924) | Donald Wesson | 1996-06-24 |
| Identifying Genes Involved in Abnormal Blood Pressure - Hypertension SCOR (NCT00005325) | Boston University | 1996-02-01 |
| Role of Endothelin in the Regulation of Vascular Tone in Patients With Essential Hypertension (NCT00001527) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-11-01 |
| Family Blood Pressure Program - GenNet Network (NCT00005268) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-09-01 |
| Family Blood Pressure Program - HyperGEN (NCT00005267) | University of Alabama at Birmingham | 1995-09-01 |
| Family Blood Pressure Program - SAPPHIRe Network (NCT00005270) | Kuakini Medical Center | 1995-09-01 |
| Family Blood Pressure Program - GENOA (NCT00005269) | The University of Texas Health Science Center, Houston | 1995-09-01 |
| Genetics of Hypertension in Blacks (NCT00005387) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-09-01 |
| Diagnosis/Pathophysiology of Glucocorticoid Remediable Aldosteronism Hypertension (NCT00005394) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-08-01 |
| Hypertension in Families of African Origin (NCT00005444) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-08-01 |
| INTERMAP: International Population Study on Macronutrients and BP (NCT00005271) | Northwestern University | 1995-07-01 |
| Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension (NCT02177331) | Boehringer Ingelheim | 1995-06-01 |
| Influence of Insulin on BP Change During Adolescence (NCT00007098) | University of Minnesota | 1995-05-01 |
| Irbesartan and Atenolol in Hypertensive Heart Disease (NCT00389168) | Karolinska Institutet | 1995-04-01 |
| Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis) (NCT00234260) | The University of Texas Health Science Center, Houston | 1995-04-01 |
| Anger and Cardiovascular Risk in Urban Youth (NCT00005383) | National Heart, Lung, and Blood Institute (NHLBI) | 1995-01-01 |
| Physical Training and Blood Pressure in High Risk Youths (NCT00005695) | Augusta University | 1995-01-01 |
| Sleep Heart Health Study (SHHS) Data Coordinating Center (NCT00005275) | Johns Hopkins Bloomberg School of Public Health | 1994-09-01 |
| Molecular Epidemiology of Essential Hypertension (NCT00005377) | The University of Texas Health Science Center, Houston | 1994-07-01 |
| Impact of Sleep Disordered Breathing in Older Adults (NCT00005378) | National Heart, Lung, and Blood Institute (NHLBI) | 1994-07-01 |
| Stress Reduction and Atherosclerotic CVD in Blacks (NCT00000546) | National Heart, Lung, and Blood Institute (NHLBI) | 1994-03-01 |
| Race, Class, and Gender--Studies of Health Effects (NCT00005443) | National Heart, Lung, and Blood Institute (NHLBI) | 1994-01-01 |
| Potential Risk Factors for Stroke (NCT00001368) | National Institute of Neurological Disorders and Stroke (NINDS) | 1993-10-01 |
| Psychosocial Factors and Cardiovascular Disease (NCT00005315) | Columbia University | 1993-09-01 |